A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC

Clinical trial NCT06769295 · RECRUITING

Trial details

NCT number: NCT06769295
Sponsor: Sichuan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2025-02-01
Primary completion: 2026-12-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.